KeyBanc analyst Scott Schoenhaus raised the firm’s price target on Progyny to $50 from $45 and keeps an Overweight rating on the shares. Progyny reported another solid top- and bottom-line beat with record utilization that hit 0.50% for females only and 0.57% for all members, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PGNY: